Investors Reata Pharmaceuticals, Inc. is a private company headquartered in Irving, Texas, focused on delivering novel medicines for difficult-to-treat
http://investors.reatapharma.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
1 seconds
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
40
SITE IP
23.215.102.19
LOAD TIME
0.953 sec
SCORE
6.2
Investor Overview | Reata Pharmaceuticals | investors.reatapharma.com Reviews
https://investors.reatapharma.com
Investors Reata Pharmaceuticals, Inc. is a private company headquartered in Irving, Texas, focused on delivering novel medicines for difficult-to-treat
Our Story | Home
http://reatapharma.com/about-us/our-story
PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Creating New Opportunities for Patients. PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Bardoxolone methyl (formerly designated as RTA 402) is currently in a Phase 2 ( LARIAT. Omaveloxolone is in a Phase 1b/2 study in me...
In-Licensing | Home
http://reatapharma.com/our-science/in-licensing
PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Creating New Opportunities for Patients. PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. New or unknown targets. Unique approaches to modulating validated targets. First-in-class or best-in-class potential. Efficacy in an...
Omaveloxolone|Friedreich’s Ataxia | Home
http://reatapharma.com/product-pipeline/rare-diseases/friedreichs-ataxia
PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Creating New Opportunities for Patients. PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Omaveloxolone Friedreich’s Ataxia. PH - ILD - CTD. PH - ILD - IPF. PH - ILD - Sarc. PH - ILD - NSIP. Since patients suffering from F...
Reata Enrolls First Patient in the MOTOR Study, a Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Mitochondrial Myopathies | Home
http://reatapharma.com/reata-enrolls-first-patient-in-the-motor-study-a-phase-2-study-of-the-safety-efficacy-and-pharmacodynamics-of-rta-408-in-the-treatment-of-mitochondrial-myopathies
PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Creating New Opportunities for Patients. PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Reata Enrolls First Patient in the…. IRVING, Texas, July 8, 2015. The primary efficacy endpoint is the change in peak workload (Watt...
Bard|Pulmonary Arterial Hypertension | Home
http://reatapharma.com/product-pipeline/cardiovascular/pulmonary-arterial-hypertension
PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Creating New Opportunities for Patients. PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Bard Pulmonary Arterial Hypertension. Bard Pulmonary Arterial Hypertension. PH - ILD - CTD. PH - ILD - IPF. PH - ILD - Sarc. PH can ...
Rare Diseases | Home
http://reatapharma.com/product-pipeline/rare-diseases
PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Creating New Opportunities for Patients. PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. PH - ILD - CTD. PH - ILD - IPF. PH - ILD - Sarc. PH - ILD - NSIP. In preclinical studies, activation of Nrf2 increases production of...
Careers | Home
http://reatapharma.com/careers
PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Creating New Opportunities for Patients. PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Open positions and job descriptions will be posted in the sections below. Investors & News.
Hsp Modulators | Home
http://reatapharma.com/our-science/hsp
PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Creating New Opportunities for Patients. PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Neuroprotective Heat Shock Protein Modulators. And function, play important roles in multiple aspects of the cellular stress respons...
News Room | Home
http://reatapharma.com/investors-news/news-room
PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Creating New Opportunities for Patients. PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Investors & News.
Overview | Home
http://reatapharma.com/product-pipeline/rare-diseases/overview
PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. Creating New Opportunities for Patients. PH – ILD – CTD. PH – ILD – IPF. PH – ILD – Sarc. PH – ILD – NSIP. Investors & News. News & Events. Events & Presentations. Proxy & Annual Report. Documents & Charters. PH - ILD - CTD. PH - ILD - IPF. PH - ILD - Sarc. PH - ILD - NSIP. In preclinical studies, activation of Nrf2 increases production of...
TOTAL LINKS TO THIS WEBSITE
40
Investors – RBS
Skip to main content. View all About us. Supplying goods and services. Where we do business. Board and governance overview. Compliance statement and remuneration policy. CEO and board overview. Group performance and remuneration committee. Group nominations and governance committee. Technology and innovation committee. View all Our brands. Royal Bank of Scotland. Isle of Man Bank. View all News and opinion. View all Sustainable Banking. Sustainable Banking at RBS. Sustainable Banking at RBS. Royal Bank o...
RCS Group - Investor Relations
If you receive an email from RCS offering RCS Loans at very discounted rates, please do not respond. These emails are not from RCS we would never request personal customer information in such an unsecured way. Please call 0861 SAY RCS should you have any queries. Term":"Apply for a card","link":"/cards"},{"term":"Apply for a loan","link":"/loans"},{"term":"Insurance products","link":"/insurance"},{"term":"Customer Protection Insurance","link":"/insurance/customer-protection-insurance"},{"term":"Accidenta...
Great Oportunities - Tucson Real Estate Investors
Take advantage of low rates, prices and high yields! Below are some great opportunities, click on text for more info:. St, Listed at $128,200, Estimated market price $160,000, Auction ends 08/05/14. 2601 S 7th Ave, Listed at $37,300, Estimated market price $105,000, Auction ends 08/14/14. 5834 E Farimount St, Listed at $82,200, Estimated market price $109,000, Auction ends 08/14/14. 3031 N Desert Dr, Listed at $107,500, Estimated market price 115,000, Auction ends 08/14/14.
Investors Overview - Realty Income Corporation
Fact Sheet and Investment Facts. Annual Reports and Meetings. Direct Stock Purchase and. Email Alerts Sign Up. The Magic of Rising Dividends. How We Generate Dividends. Receive Realty Income Dividends. Email Alerts Sign Up. Jul 29, 2015. Realty Income Announces Record Operating Results For Second Quarter And First Six Months Of 2015. Jul 14, 2015. 541st Consecutive Common Stock Monthly Dividend Declared By Realty Income. Jul 1, 2015. Realty Income To Report Second Quarter 2015 Operating Results.
Investor Overview | Reata Pharmaceuticals
Creating New Opportunities for Patients. Proxy and Annual Report. Proxy and Annual Report. Reata Pharmaceuticals, Inc. (Nasdaq: RETA) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in regulating cellular metabolism and inflammation. Our two most advanced clinical candidates (bardoxolone methyl and omaveloxolone) target important transcription factors, called Nrf2 and NF-...
Recall - Investor Relations - Investor Home
Digital and Physical Content. Recall solutions empower you to make the right business decision while complying with increasing regulations. Recall solutions empower you to make the right business decision while complying with increasing regulations. Recall solutions empower you to make the right business decision while complying with increasing regulations. Document and Information Management. Document and Information Management. Information Life Cycle Management. Document Management Audit Reporting.
investors.recoveryenergyco.com
Lilis Energy Inc. | Investor Center | Investor Center
Investor Presentation May 2015. Lilis Energy, Inc. is a Denver-based independent oil and gas exploration and production company focused on the Denver-Julesburg (DJ) Basin where it holds approximately 37,000 gross (31,000 net) acres. Lilis Energy to Upsize Acquisition of Core Wattenberg Acreage and Production. Lilis Energy Signs Agreement to Acquire Core Wattenberg Acreage and Production for $5.5 Million. Lilis Energy Names Kevin Nanke Chief Financial Officer. There are currently no events scheduled.
Red Hat
Skip to main content. Log in to your Red Hat account. Your Red Hat account gives you access to your member profile and preferences, and the following services based on your customer status:. Red Hat Connect for Business Partners. Here are a few reasons why you should be:. Browse Knowledgebase articles, manage support cases and subscriptions, download updates, and more from one place. View users in your organization, and edit their account information, preferences, and permissions. All courses and exams.
Red Robin - Investors - Investor Relations
Other Fun On A Bun. Red Robin Gourmet Burgers, Inc., was founded on four core values: Honor, Integrity, Continually Seeking Knowledge and Having Fun. 160; 1.80. Data provided by Nasdaq. Minimum 15 minutes delayed. Menu items and pricing may vary by location and are subject to change. Menu items and pricing may vary by location and are subject to change.
Redrow plc
Skip to main content. Slavery and Human Trafficking Statement. Gender Pay Gap Report. Slavery and Human Trafficking Statement. Gender Pay Gap Report. Interim Dividend Record Date. Interim Dividend Payment Date. Share price delayed by 15 mins from LSE. Find out more by watching this film. Receive email alerts for notification of new financial reports, presentations and changes to our financial calendar.
SOCIAL ENGAGEMENT